DM Full Guideline (2010) - VA/DoD Clinical Practice Guidelines Home
DM Full Guideline (2010) - VA/DoD Clinical Practice Guidelines Home
DM Full Guideline (2010) - VA/DoD Clinical Practice Guidelines Home
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Version 4.0<br />
<strong>VA</strong>/<strong>DoD</strong> <strong>Clinical</strong> <strong>Practice</strong> <strong>Guideline</strong><br />
for the Management of Diabetes Mellitus<br />
Rickheim PL, Weaver TW, Flader JL et al. Assessment of group versus individual diabetes education: a<br />
randomized study. Diabetes Care 2002; 25(2): 269-74.<br />
Riddle MC, Rosenstock J, Gerich J. The Treat-to-Target Trial: randomized addition of glargine or human NPH<br />
insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003; 26(11): 3080-6.<br />
Rith-Najarian SJ, Stolusky T, Gohdes <strong>DM</strong>. Identifying diabetic patients at high risk for lower-extremity<br />
amputation in a primary health care setting. A prospective evaluation of simple screening criteria. Diabetes<br />
Care 1992; 15(10): 1386-9.<br />
Roberts VL, Stewart J, Issa M et al. Triple therapy with glimepiride in patients with type 2 diabetes mellitus<br />
inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, doubleblind,<br />
placebo-controlled, parallel-group study. Clin Ther 2005; 27(10): 1535-47.<br />
Rosenstock J, Aguilar-Salinas C, Klein E et al. Effect of saxagliptin monotherapy in treatment-naive patients with<br />
type 2 diabetes. Curr Med Res Opin 2009; 25(10): 2401-11.<br />
Rosenstock J, Brazg R, Andryuk PJ et al. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin<br />
added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter,<br />
randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther 2006a; 28(10): 1556-68.<br />
Rosenstock J, Sugimoto D, Strange P et al. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone<br />
added to combination therapy of sulfonylurea plus metformin in insulin-naive patients. Diabetes Care<br />
2006b; 29(3): 554-9.<br />
Rubin DJ, Moshang J, Jabbour SA. Diabetes knowledge: are resident physicians and nurses adequately prepared to<br />
manage diabetes? Endocr Pract 2007; 13(1): 17-21.<br />
Rubin RJ, Dietrich KA, Hawk AD. <strong>Clinical</strong> and economic impact of implementing a comprehensive diabetes<br />
management program in managed care. J Clin Endocrinol Metab 1998; 83(8): 2635-42.<br />
Rushforth NB, Bennett PH, Steinberg AG et al. Comparison of the value of the two- and one-hour glucose levels<br />
of the oral GTT in the diagnosis of diabetes in Pima Indians. Diabetes 1975; 24(6): 538-46.<br />
Russell-Jones D, Vaag A, Schmitz O et al. LEAD-5 (Met+SU) Study Group. Liraglutide vs insulin glargine and<br />
placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5<br />
met+SU): a randomised controlled trial. Diabetologia 2009; 52(10): 2046-55.<br />
Sacco M, Pellegrini F, Roncaglioni MC et al. Primary prevention of cardiovascular events with low-dose aspirin<br />
and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes<br />
Care 2003; 26(12): 3264-72.<br />
Sadur CN, Moline N, Costa M et al. Diabetes management in a health maintenance organization. Efficacy of care<br />
management using cluster visits. Diabetes Care 1999; 22(12): 2011-7.<br />
Salpeter SR, Buckley NS, Kahn JA et al. Meta-analysis: metformin treatment in persons at risk for diabetes<br />
mellitus. Am J Med 2008; 121(2): 149-57 e2.<br />
Sarol JN, Jr., Nicodemus NA, Jr., Tan KM et al. Self-monitoring of blood glucose as part of a multi-component<br />
therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004). Curr Med Res<br />
Opin 2005; 21(2): 173-84.<br />
Savage S, Estacio RO, Jeffers B et al. Increased complications in noninsulin-dependent diabetic patients treated<br />
with insulin versus oral hypoglycemic agents: a population study. Proc Assoc Am Physicians 1997; 109(2):<br />
181-9.<br />
Scain SF, Friedman R, Gross JL. A structured educational program improves metabolic control in patients with<br />
type 2 diabetes: a randomized controlled trial. Diabetes Educ 2009; 35(4): 603-11.<br />
Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of<br />
randomised clinical trials. Diabetes Metab 2004; 30(6): 487-96.<br />
Schnipper JL, Barsky EE, Shaykevich S et al. Inpatient management of diabetes and hyperglycemia among general<br />
medicine patients at a large teaching hospital. J Hosp Med 2006; 1(3): 145-50.<br />
Scott JC, Conner DA, Venohr I et al. Effectiveness of a group outpatient visit model for chronically ill older health<br />
maintenance organization members: a 2-year randomized trial of the cooperative health care clinic. J Am<br />
Geriatr Soc 2004; 52(9): 1463-70.<br />
Scott R, Loeys T, Davies MJ et al. Efficacy and safety of sitagliptin when added to ongoing metformin therapy in<br />
patients with type 2 diabetes. Diabetes Obes Metab 2008; 10(10): 959-69.<br />
Appendices Page 143